India  
 
NewsR.in

J&J denied extension of patent on TB drug, to benefit patients

IndiaTimes Tuesday, 17 December 2024 ()
0
shares		ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Johnson & Johnson Johnson & Johnson American multinational pharmaceutical and medical device company


Tuberculosis Tuberculosis Infectious disease

Watch: Om Birla takes a swing during Rajya Sabha vs Lok Sabha cricket match

 Lok Sabha Speaker Om Birla showed off his cricketing skills in a friendly match against the Rajya Sabha Chairman XI. The match, part of the TB Mukt Bharat..
IndiaTimes

You Might Like